Magda Marquet, Ph.D.
Magda Marquet is the co-founder and co-CEO of ALMA Life Sciences LLC, an investment and consulting firm with a portfolio of twenty private investments. She is also the Chairman and co-Founder of Althea, an Ajinomoto company. Dr. Marquet is also co-founder of Althea Dx, a spin-off of Althea focusing in personalized medicine, companion diagnostics development and pharmacogenomics.
Dr. Marquet has three decades of experience in the biotechnology industry in the United States and Europe. Prior to starting Althea, she held management positions at Vical Inc., Amylin Pharmaceuticals, Protein Polymer Technologies, Syntro Corporation and Transgene.
She currently serves as a Board member for Sente, Independa and Portable Genomics. She is also co-Chairman of the Advisory Board of MD Revolution. Dr. Marquet was Chairman of BIOCOM (2013-2014) and is Chair of the Board of Visitors of the UCSD Moores Cancer Center. She serves as a Director of the Economic Development Corporation (EDC- Executive Committee) and of the Kyoto Symposium Organization. She is also a member of the UCSD Biological Sciences Dean Leadership Council.
Dr. Marquet holds a Ph.D in Biochemical Engineering from INSA/University of Toulouse, France. She has received numerous awards throughout her career including the 2005 Regional Ernst & Young Entrepreneur of the Year Award in the Life Sciences category, the Athena Pinnacle Award and the Exemplary Service Award from the San Diego Business Journal. She is the first woman inducted in the CONNECT Entrepreneur Hall of Fame (2016).
Chairman, Ajinomoto Althea Inc.